Literature DB >> 33529233

Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure.

Sara C Johnston1, Keersten M Ricks2, Alexandra Jay3, Jo Lynne Raymond4, Franco Rossi3, Xiankun Zeng4, Jennifer Scruggs4, David Dyer3, Ondraya Frick3, Jeffrey W Koehler2, Paul A Kuehnert2, Tamara L Clements2, Charles J Shoemaker2, Susan R Coyne2, Korey L Delp2, Joshua Moore3, Kerry Berrier3, Heather Esham3, Joshua Shamblin3, Willie Sifford3, Jimmy Fiallos3, Leslie Klosterman3, Stephen Stevens3, Lauren White3, Philip Bowling3, Terrence Garcia3, Christopher Jensen3, Jeanean Ghering3, David Nyakiti3, Stephanie Bellanca3, Brian Kearney5, Wendy Giles3, Nazira Alli3, Fabian Paz3, Kristen Akers5, Denise Danner5, James Barth5, Joshua A Johnson5, Matthew Durant5, Ruth Kim5, Jay W Hooper1, Jeffrey M Smith1, Jeffrey R Kugelman6, Brett F Beitzel6, Kathleen M Gibson5, Margaret L M Pitt7, Timothy D Minogue2, Aysegul Nalca8.   

Abstract

Airborne transmission is predicted to be a prevalent route of human exposure with SARS-CoV-2. Aside from African green monkeys, nonhuman primate models that replicate airborne transmission of SARS-CoV-2 have not been investigated. A comparative evaluation of COVID-19 in African green monkeys, rhesus macaques, and cynomolgus macaques following airborne exposure to SARS-CoV-2 was performed to determine critical disease parameters associated with disease progression, and establish correlations between primate and human COVID-19. Respiratory abnormalities and viral shedding were noted for all animals, indicating successful infection. Cynomolgus macaques developed fever, and thrombocytopenia was measured for African green monkeys and rhesus macaques. Type II pneumocyte hyperplasia and alveolar fibrosis were more frequently observed in lung tissue from cynomolgus macaques and African green monkeys. The data indicate that, in addition to African green monkeys, macaques can be successfully infected by airborne SARS-CoV-2, providing viable macaque natural transmission models for medical countermeasure evaluation.

Entities:  

Year:  2021        PMID: 33529233     DOI: 10.1371/journal.pone.0246366

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  19 in total

1.  Overview of Nonhuman Primate Models of SARS-CoV-2 Infection.

Authors:  Anita M Trichel
Journal:  Comp Med       Date:  2021-09-21       Impact factor: 0.982

2.  Natural Transmission and Experimental Models of SARS CoV-2 Infection in Animals.

Authors:  Jessica C Gomes Noll; Gabriela M do Nascimento; Diego G Diel
Journal:  Comp Med       Date:  2021-10-26       Impact factor: 0.982

3.  Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate species.

Authors:  Alyssa C Fears; Brandon J Beddingfield; Nicole R Chirichella; Nadia Slisarenko; Stephanie Z Killeen; Rachel K Redmann; Kelly Goff; Skye Spencer; Breanna Picou; Nadia Golden; Cecily C Midkiff; Duane J Bush; Luis M Branco; Matthew L Boisen; Hongmei Gao; David C Montefiori; Robert V Blair; Lara A Doyle-Meyers; Kasi Russell-Lodrigue; Nicholas J Maness; Chad J Roy
Journal:  PLoS Pathog       Date:  2022-07-05       Impact factor: 7.464

Review 4.  Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes.

Authors:  Shambhunath Choudhary; Isis Kanevsky; Lindsay Tomlinson
Journal:  Vet Pathol       Date:  2022-04-22       Impact factor: 3.157

Review 5.  Animal models for COVID-19: advances, gaps and perspectives.

Authors:  Changfa Fan; Yong Wu; Xiong Rui; Yuansong Yang; Chen Ling; Susu Liu; Shunan Liu; Youchun Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

Review 6.  Animal Models of COVID-19 II. Comparative Immunology.

Authors:  Rebecca T Veenhuis; Caroline J Zeiss
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

Review 7.  COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns.

Authors:  Mohamed Joma; Claire-Maelle Fovet; Nabila Seddiki; Pierre Gressens; Mireille Laforge
Journal:  Vaccines (Basel)       Date:  2021-04-15

8.  SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing.

Authors:  Nazima Habibi; Saif Uddin; Montaha Behbehani; Nasreem Abdul Razzack; Farhana Zakir; Anisha Shajan
Journal:  Infect Prev Pract       Date:  2021-12-27

9.  Indoor Model Simulation for COVID-19 Transport and Exposure.

Authors:  Tareq Hussein; Jakob Löndahl; Sara Thuresson; Malin Alsved; Afnan Al-Hunaiti; Kalle Saksela; Hazem Aqel; Heikki Junninen; Alexander Mahura; Markku Kulmala
Journal:  Int J Environ Res Public Health       Date:  2021-03-12       Impact factor: 3.390

Review 10.  The existence, spread, and strategies for environmental monitoring and control of SARS-CoV-2 in environmental media.

Authors:  Zhongchuang Liu; Krzysztof Skowron; Katarzyna Grudlewska-Buda; Natalia Wiktorczyk-Kapischke
Journal:  Sci Total Environ       Date:  2021-07-07       Impact factor: 7.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.